Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration
Nathalie Saurat, Andrew P. Minotti, Maliha T. Rahman, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1162-1174.e8
Open Access | Times Cited: 10

Showing 10 citing articles:

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions
Isabel Lam, Alain Ndayisaba, Amanda J. Lewis, et al.
Neuron (2024) Vol. 112, Iss. 17, pp. 2886-2909.e16
Open Access | Times Cited: 10
Brain aging and rejuvenation at single-cell resolution
Eric Sun, Rahul Nagvekar, Angela N. Pogson, et al.
Neuron (2025) Vol. 113, Iss. 1, pp. 82-108
Open Access
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Belén Calvo, Pierre Schembri-Wismayer, María Beatriz Durán Alonso
Cells (2025) Vol. 14, Iss. 5, pp. 347-347
Open Access
Generation of stable Cas9-EGFP expressing human induced pluripotent stem cell lines based on SeLection by Essential-gene Exon Knock-in technology
Yao Zhang, Zijun Lu, Hao Yang, et al.
Stem Cell Research (2025), pp. 103710-103710
Open Access
CRISPR screens in neurological research: exploring the functional basis of aging and disease
Jenny Straiton
BioTechniques (2025), pp. 1-4
Open Access
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
Bowei Liu, Zhigang Peng, Hao Zhang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
CRISPR/Cas9-Based therapeutics as a promising strategy for management of Alzheimer’s disease: progress and prospects
Mohamad Sultan Khan, Nousheen Qureshi, Rehan Khan, et al.
Frontiers in Cellular Neuroscience (2025) Vol. 19
Open Access
High-Throughput Screening to Identify Novel Compounds Affecting the Genome Editing Efficiency of CRISPR System
Jiasong Chang, Xiulong Yang, Tong Zhang, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1811-1811
Open Access
Neddylation of protein, a new strategy of protein post-translational modification for targeted treatment of central nervous system diseases
Qian Wu, Ziang Geng, Lu Jun, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
A comprehensive review on DCN1 protein, inhibitors and their therapeutic applications
Zhangxu He, Ziqiao Yuan, Feifei Yang, et al.
International Journal of Biological Macromolecules (2024) Vol. 277, pp. 134541-134541
Closed Access
The long road to the development of stem cells as a model for central nervous system health and disease
Hyunjin Kim, Aaron B. Bowman
Advances in neurotoxicology (2024), pp. 1-45
Closed Access
State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons
Valentina Basso, Máté D. Döbrössy, Lachlan H. Thompson, et al.
Biology (2024) Vol. 13, Iss. 9, pp. 690-690
Open Access
Page 1

Scroll to top